{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:10:37Z","timestamp":1778623837484,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jmii.2022.03.007","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T22:07:06Z","timestamp":1650924426000},"page":"387-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures"],"prefix":"10.1016","volume":"55","author":[{"given":"Wenxia","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daojun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2022.03.007_bib1","doi-asserted-by":"crossref","first-page":"751778","DOI":"10.3389\/fimmu.2021.751778","article-title":"The global epidemic of the SARS-CoV-2 delta variant, key spike mutations and immune escape","volume":"12","author":"Tian","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmii.2022.03.007_bib2","doi-asserted-by":"crossref","first-page":"646333","DOI":"10.3389\/fimmu.2021.646333","article-title":"Cellular immune response to COVID-19 and potential immune modulators","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jmii.2022.03.007_bib3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/jmv.27563","article-title":"Omicron (B.1.1.529) variant: development, dissemination, and dominance","volume":"94","author":"Rahmani","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib4","series-title":"Classification of omicron (B.1.1.529): SARS-CoV-2 variant of concern","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.jmii.2022.03.007_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMc2119270","article-title":"Effectiveness of BNT162b2 vaccine against omicron variant in South Africa","volume":"386","author":"Collie","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2022.03.007_bib6","series-title":"Covariants","year":"2021"},{"key":"10.1016\/j.jmii.2022.03.007_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jmv.27376","article-title":"The global epidemic of SARS-CoV-2 variants and their mutational immune escape","volume":"94","author":"Tian","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib8","unstructured":"University. S. CORONAVIRUS ANTIVIRAL & RESISTANCE DATABASE. https:\/\/covdb.stanford.edu\/page\/susceptibility-data\/. Last updated on 12\/23\/2021, 4:09:41 PM."},{"key":"10.1016\/j.jmii.2022.03.007_bib9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jmii.2022.03.007_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jmii.2022.03.007_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cell.2020.11.020","article-title":"Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity","volume":"184","author":"Volz","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jmii.2022.03.007_bib12","first-page":"443686","article-title":"Impacts on the structure-function relationship of SARS-CoV-2 spike by B.1.1.7 mutations","volume":"5","author":"Yang","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jmii.2022.03.007_bib13","doi-asserted-by":"crossref","first-page":"2002106","DOI":"10.2807\/1560-7917.ES.2020.26.1.2002106","article-title":"Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020","volume":"26","author":"Leung","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jmii.2022.03.007_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/vaccines9060616","article-title":"A unique SARS-CoV-2 spike protein P681H variant detected in Israel","volume":"9","author":"Zuckerman","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jmii.2022.03.007_bib15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/jmv.26653","article-title":"Kidney involvement in COVID-19 and its treatments","volume":"93","author":"Han","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib16","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/jmv.26036","article-title":"Hepatic complications of COVID-19 and its treatment","volume":"92","author":"Tian","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib17","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1002\/ehf2.12960","article-title":"Crosstalk between coronavirus disease 2019 and cardiovascular disease and its treatment","volume":"7","author":"Ye","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jmii.2022.03.007_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00277-020-04305-x","article-title":"Characteristics of coagulation alteration in patients with COVID-19","volume":"100","author":"Luo","year":"2021","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmii.2022.03.007_bib19","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.00148.2020","article-title":"The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19","volume":"319","author":"Ye","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jmii.2022.03.007_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(21)00144-6","article-title":"South Africa responds to new SARS-CoV-2 variant","volume":"397","author":"Makoni","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2022.03.007_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41591-021-01397-4","article-title":"SARS-CoV-2 variants of concern are emerging in India","volume":"27","author":"Singh","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jmii.2022.03.007_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jmv.27376","article-title":"The global epidemic of SARS-CoV-2 variants and their mutational immune escape","volume":"94","author":"Tian","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib23","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/jmv.27562","article-title":"Omicron and S-gene target failure cases in the highest COVID-19 case rate region in Canada - december 2021","volume":"94","author":"Li","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib24","unstructured":"Frequently asked questions for the B.1.1.529 mutated SARS-COV-2 lineage in South Africa. https:\/\/www.nicd.ac.za\/frequentlyasked-questions-for-the-b-1-1-529-mutated-sars-cov-2-lineage-in-south-africa\/. 2021."},{"key":"10.1016\/j.jmii.2022.03.007_bib25","doi-asserted-by":"crossref","first-page":"n3013","DOI":"10.1136\/bmj.n3013","article-title":"Covid-19: South Africa\u2019s surge in cases deepens alarm over omicron variant","volume":"375","author":"Dyer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jmii.2022.03.007_bib26","series-title":"Enhancing readiness for omicron (B.1.1.529): technical brief and priority actions for member States","year":"2021"},{"key":"10.1016\/j.jmii.2022.03.007_bib27","unstructured":"Omicron Variant: What You Need to Know. Updated Dec. 10, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/omicron-variant.html. 2021."},{"key":"10.1016\/j.jmii.2022.03.007_bib28","unstructured":"COVID-19 variants identified in the UK. https:\/\/www.gov.uk\/government\/news\/covid-19-variants-identified-in-the-uk. 2021."},{"key":"10.1016\/j.jmii.2022.03.007_bib29","series-title":"Epidemiological update: omicron variant of concern (VOC) \u2013 data as of 19 December 2021 (12:00)","year":"2021"},{"key":"10.1016\/j.jmii.2022.03.007_bib30","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2022.03.007_bib31","first-page":"21266068","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa","volume":"11","author":"Pulliam","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jmii.2022.03.007_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jmii.2022.03.007_bib33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jmii.2022.03.007_bib34","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jmv.27526","article-title":"Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein","volume":"94","author":"Kumar","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib35","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1002\/jmv.27210","article-title":"SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?","volume":"93","author":"Pascarella","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib36","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/jmv.27528","article-title":"The electrostatic potential of the Omicron variant spike is higher than in Delta and Delta-plus variants: a hint to higher transmissibility?","volume":"94","author":"Pascarella","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib37","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1002\/jcla.23937","article-title":"Analysis of COVID-19 vaccines: types, thoughts, and application","volume":"35","author":"Han","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jmii.2022.03.007_bib38","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/jmv.27513","article-title":"The variants of SARS-CoV-2 and the challenges of vaccines","volume":"94","author":"Han","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2022.03.007_bib39","series-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa","author":"Pulliam","year":"2021"},{"key":"10.1016\/j.jmii.2022.03.007_bib40","unstructured":"Latest updates 12 Dec 2021. on SARS-CoV-2 variants detected in the UK. https:\/\/www.gov.uk\/government\/news\/covid-19-variants-identified-in-the-uk. 2021."},{"key":"10.1016\/j.jmii.2022.03.007_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/22221751.2021.2017757","article-title":"The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.jmii.2022.03.007_bib42","first-page":"21267594","article-title":"Estimates of reduced vaccine effectiveness against hospitalization, infection, transmission and symptomatic disease of a new SARS-CoV-2 variant, Omicron (B.1.1.529), using neutralizing antibody titers","volume":"12","author":"Gardner","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jmii.2022.03.007_bib43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMc2119358","article-title":"Third BNT162b2 vaccination neutralization of SARS-CoV-2 omicron infection","volume":"386","author":"Nemet","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2022.03.007_bib44","doi-asserted-by":"crossref","first-page":"2101146","DOI":"10.2807\/1560-7917.ES.2021.26.50.2101146","article-title":"Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021","volume":"26","author":"Espenhain","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jmii.2022.03.007_bib45","first-page":"21267417","article-title":"SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection","volume":"12","author":"Cele","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jmii.2022.03.007_bib46","doi-asserted-by":"crossref","first-page":"2101147","DOI":"10.2807\/1560-7917.ES.2021.26.50.2101147","article-title":"Outbreak caused by the SARS-CoV-2 omicron variant in Norway, november to december 2021","volume":"26","author":"Brandal","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jmii.2022.03.007_bib47","first-page":"ciab1041","article-title":"Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients","author":"Lu","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2022.03.007_bib48","unstructured":"Reuters . December 12, 2021. Israeli study finds Pfizer COVID-19 booster protects against Omicron.https:\/\/www.reuters.com\/world\/middle-east\/israeli-study-finds-pfizer-covid-19-booster-protects-against-omicron-2021-12-11\/."},{"key":"10.1016\/j.jmii.2022.03.007_bib49","unstructured":"Pfizer. Pfizer and BioNTech Provide Update on Omicron Variant. Press release. Wednesday, December 08, 2021 - 06:54am. https:\/\/www.pfizer.com\/news\/press-release\/press-releasedetail\/pfizer-and-biontech-provide-update-omicron-variant. (Last accessed December 12, 2021."},{"key":"10.1016\/j.jmii.2022.03.007_bib50","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mco2.110","article-title":"SARS-CoV-2 Omicron variant: characteristics and prevention","volume":"16","author":"He","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.jmii.2022.03.007_bib51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2020.10.012","article-title":"Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies","volume":"538","author":"Yuan","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jmii.2022.03.007_bib52","first-page":"21265694","article-title":"Comparative genomics and characterization of SARS-CoV-2 P.1 (gamma) variant of concern (VOC) from Amazonas, Brazil","volume":"10","author":"Zimerman","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jmii.2022.03.007_bib53","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.xcrm.2021.100255","article-title":"Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016","volume":"2","author":"Starr","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jmii.2022.03.007_bib54","series-title":"B.1.1.529 escape the majority of SARS-CoV-2 neutralizing antibodies of diverse epitopes","author":"Cao","year":"2021"},{"key":"10.1016\/j.jmii.2022.03.007_bib55","series-title":"Reduced neutralization of SARS-CoV-2 omicron variant by vaccine sera and monoclonal antibodies","author":"Wilhelm","year":"2021"},{"key":"10.1016\/j.jmii.2022.03.007_bib56","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1515\/cclm-2021-1287","article-title":"Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants","volume":"60","author":"Lippi","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jmii.2022.03.007_bib57","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/S2666-5247(21)00302-5","article-title":"SARS-CoV-2 antigen-detecting rapid tests for the delta variant","volume":"3","author":"Bekliz","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jmii.2022.03.007_bib58","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","article-title":"The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic","volume":"185","author":"Hoffmann","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jmii.2022.03.007_bib59","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jmii.2022.03.007_bib60","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/vaccines9080918","article-title":"mRNA vaccines enhance neutralizing immunity against sars-cov-2 variants in convalescent and chadox1-primed subjects","volume":"9","author":"Fabricius","year":"2021","journal-title":"Vaccines (Basel)"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222000548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222000548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:27:46Z","timestamp":1761658066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118222000548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1684118222000548"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2022.03.007","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges of SARS-CoV-2 Omicron Variant and appropriate countermeasures","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2022.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}